Urology Specialists Logo

Meet Our Providers


Our Locations

Focal Laser Ablation (FLA)

Novel Focal Prostate Cancer Therapy

Prostate cancer is one of the most common cancers in men. When diagnosed, exploring all treatment options is crucial to making an informed decision about your health.

Focal Laser Ablation (FLA)

Focal Laser Ablation (FLA) is an alternative prostate disease treatment to active surveillance and radical therapies that maintains patients’ quality of life.

Focal Laser Ablation (FLA) for prostate cancer is a minimally invasive treatment that uses precise laser technology to target and destroy cancerous prostate tissue. Guided by advanced imaging such as MRI and ultrasound, FLA accurately pinpoints the lesion and delivers focused heat directly to it. Unlike more aggressive treatments that apply high energy or reset the entire gland—often removing excess tissue—FLA minimizes trauma to surrounding organs like the urethra and bladder neck and sphincter, reducing the risk of complications, which are common with radical treatment options.[1]

About the outcomes

The best outcomes for focal laser ablation are generally seen in men with localized low to intermediate prostate cancer, where the cancer has not spread beyond the prostate gland. According to recent studies, patients who undergo this procedure often experience[2,3]:

  •  Effective reduction or elimination of cancerous tissue
  •  Minimal damage to surrounding healthy tissue
  •  Lower risk of complications compared to traditional treatments
  •  Faster recovery times

Echolaser TPLA

The Echolaser TPLA procedure is a Focal Laser Ablation therapy that involves the insertion of multiple ultra-thin needles through the skin in the perineal area (between the anus and scrotum), directly into the prostate. Guided by real-time ultrasound imaging, these needles precisely position tiny laser fibers within the prostate. The laser fibers then deliver targeted heat to ablate (destroy) only the affected prostate tissue, leaving surrounding healthy tissue intact.

Over time, your body naturally reabsorbs the treated tissue, which may result in a reduction in prostate size while preserving normal urinary function and quality of life[4]. The procedure is typically performed in an outpatient setting under local anesthesia, allowing you to return home the same day.

Tough on the disease. Gentle on the patient 

  • No incision. General anesthesia optional
  • In-office/outpatient
  • Preserves ejaculation and erectile functions [4,5]
  • Return quickly to regular activities

INDIVIDUAL RESULTS MAY VARY.
This material provides general information about our medical device and its potential benefits. However, it is essential to consult with a qualified healthcare professional (such as a doctor or specialist) before using this device. Individual health conditions and medical history can vary, and only a qualified healthcare professional can assess whether this device is suitable for your specific needs.

REFERENCES

  1. Piramide F, Veccia A, Tzelves L, Nikles S, Ortega Polledo le, Nocera L, et al. Sexual function outcomes in men undergoing minimal invasive ablative techniques for prostate cancer: a ESRU/yaU urotech systematic review and pooled analysis. Minerva Urol Nephrol 2025;77:285-97
  2. Rakauskas A, Marra G, Heidegger I, Kasivisvanathan V, Kretschmer A, Zattoni F, Preisser F, Tilki D, Tsaur I, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G, Valerio M. Focal Therapy for Prostate Cancer: Complications and Their Treatment. Front Surg. 2021 Jul 12;8:69624
  3. Rocio Roldan-Testillano, Lara Rodriguez-Sanchez, Claudia Covarrubias, Francisco Durazo-Ruiz, Adel Arezki, Maurice Anidjar, Rafael Sanchez-Salas, Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions,Prostate International, 2025, ISSN 2287-8882,
  4. Manenti G, Perretta T, Nezzo M, Fraioli FR, Carreri B, Gigliotti PE, Micillo A, Malizia A, Di Giovanni D, Ryan CP, et al. Transperineal Laser Ablation (TPLA) Treatment of Focal Low–Intermediate Risk Prostate Cancer. Cancers. 2024; 16(7):1404.
  5. Iacovelli, V.; Carilli, M.; Bertolo, R.; Forte, V.; Vittori, M.; Filippi, B.; Di Giovanni, G.; Cipriani, C.; Petta, F.; Maiorino, F.; et al. Transperineal Laser Ablation for Focal Therapy of Localized Prostate Cancer: 12-Month Follow-up Outcomes from a Single Prospective Cohort Study. Cancers 2024

INDICATION FOR USE
Echolaser TPLA is FDA cleared for Soft Tissue Ablation in Urology

Smiling doctor consoling senior adult patient in medical clinic. Kind caring therapist or caregiver helping older retired man talking, giving comfort, expressing care concept.

Prostate cancer treatment has come a long way

(and men couldn’t be more thankful)

HIFU - Prostate Cancer Treatment - Designed to Minimize Side-Effects and Maximize Lifestyle
Improving the Fight Against BPH with Dr. Smith, Interventional Radiologist and Dr. Mistry, Urologist